Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Self-amplifying RNA Synthesis Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom Synthesis Services), Application ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Keylicon Biosciences is pleased to announce its exclusive rights to a groundbreaking next-generation RNA technology developed at ...

Scientists at Queen Mary University of London have found a way to overcome cells' natural defenses against self-amplifying mRNA vaccines, allowing the cells to produce significantly more of the target ...

The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential. However, due to ...

Maximize capping efficiency and minimize double-stranded RNA ("dsRNA") in the manufacturing of self-amplifying mRNA SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a company ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A single self‑amplifying RNA injection that boosts a heart‑healing peptide cut scarring and ...

Eight vaccine research projects will share £33.2m in government funding to develop new vaccine tech and strengthen pandemic preparedness.

The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was previously imaginable, and opens new possibilities in gene therapy, cancer ...

A new study led by scientists at Queen Mary University of London describes a way to overcome a cell’s natural defenses against self-amplifying RNA vaccines. According to details provided in a new ...

SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, today announced the launch of Prima RNApols™ ExTend Cap AU, ...